Resource Guide: Clinical evidence review: Reglan and Tardive Dyskinesia

An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.

In-depth resource

Clinical evidence review: Reglan and Tardive Dyskinesia — detailed background and analysis.

MedlinePlus — Trusted Health Information

Reference: MedlinePlus — Trusted Health Information

Authoritative source for clinical, regulatory, and public-health background reading.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.